CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Catalyst Types

Browse biotech catalysts by type. Currently tracking 1254 upcoming events.

640
Phase 2 Trials
Mid-stage clinical trial results and efficacy data
534
Phase 3 Trials
Late-stage clinical trial results and data readouts
80
PDUFA Dates
FDA target action dates for drug approval decisions
0
AdCom Meetings
FDA Advisory Committee meetings and votes
0
BLA Filings
Biologics License Application submissions
0
Conferences
Medical conference presentations and data releases
0
Earnings
Quarterly earnings reports with pipeline updates
0
NDA Filings
New Drug Application submissions to FDA
0
Phase 1 Trials
Early-stage safety and dosing trial results
0
Publications
Scientific journal publications and research papers

Understanding Biotech Catalyst Types

Biotech catalysts are key events that can significantly impact a company's stock price. CatalystAlert tracks multiple types of catalysts to help investors stay informed about upcoming opportunities and risks in the biotechnology sector.

PDUFA Dates

PDUFA (Prescription Drug User Fee Act) dates are FDA target action dates for drug approval decisions. These are among the most important catalysts for biotech investors as they represent binary events with significant stock price implications.

Clinical Trial Results

Phase 1, 2, and 3 clinical trial results provide critical data on drug safety and efficacy. Phase 3 readouts are particularly significant as they often determine whether a drug will be submitted for FDA approval.

FDA Advisory Committee (AdCom) Meetings

AdCom meetings bring together external experts to review drug applications and provide recommendations to the FDA. While not binding, AdCom votes are often followed by the FDA and can signal approval or rejection.